Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea · Delayed Price · Currency is KRW 7,120.00
-520.00 (-6.81%)
At close: Apr 2, 2026
Kyongbo Pharmaceutical Market Cap
Kyongbo Pharmaceutical has a market cap or net worth of 170.22 billion as of April 2, 2026. Its market cap has increased by 13.02% in one year.
Market Cap
170.22B
Enterprise Value
288.84B
Revenue
264.10B
Ranking
n/a
PE Ratio
933.75
Stock Price
7,120.00
Market Cap Chart
Since June 29, 2015, Kyongbo Pharmaceutical's market cap has decreased from 818.81B to 170.22B, a decrease of -79.21%. That is a compound annual growth rate of -13.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 169.26B | 22.70% |
| Dec 30, 2025 | 137.94B | -7.23% |
| Dec 30, 2024 | 148.70B | -25.86% |
| Dec 28, 2023 | 200.58B | -16.10% |
| Dec 29, 2022 | 239.07B | -6.98% |
| Dec 30, 2021 | 257.00B | -34.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AptaBio Therapeutics | 203.68B |
| Jeil Pharmaceutical Co.,Ltd | 203.27B |
| Ilyang Pharmaceutical Co.,Ltd | 200.40B |
| JW Lifescience | 199.91B |
| Whan In Pharm | 194.64B |
| REYON Pharmaceutical | 184.14B |
| SAMSUNG PHARM. Co., LTD. | 172.99B |
| Daihan Pharmaceutical | 171.11B |